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TO THE EDITOR
Harlequin ichthyosis (HI) is a hereditary
skin disorder characterized by severe
hyperkeratosis and impaired skin barrier
function (Moskowitz et al., 2004; Akiya-
ma et al., 2005). We have identified the
ATP-binding cassette transporter A12
(ABCA12) as the causative gene of HI
and, furthermore, demonstrated that
ABCA12 is essential for keratinocyte lipid
transport (Akiyama et al., 2005; Yanagi
et al., 2008). Loss of ABCA12 function
causes lipid transport to be defective in
keratinocytes of the upper spinous and
granular layers, resulting in the deposi-
tion of numerous intracellular lipid dro-
plets and malformation of intercellular
lipid layers (Akiyama et al., 2005; Yanagi
et al., 2010). Recently, we have shown
that gangliosides accumulate in the differ-
entiated keratinocytes of HI patients
(Mitsutake et al., 2010). On the basis of
the evidence that lipid accumulation is
involved in keratinocyte apoptosis (Wang
et al., 2001; Uchida et al., 2010), we
investigated apoptotic and anti-apoptotic
parameters in skin samples from HI
patients and Abca12/ HI model mice.
We studied the skin of two HI
patients and that of Abca12/ mice.
The ABCA12 mutations of the two HI
patients have been previously reported:
one patient has the homozygous splice
acceptor site mutation c.3295-2A4G
and the other has the homozygous
nonsense mutation p.Arg434X (Akiya-
ma et al., 2005). The procedure for
generating Abca12/ mice, the estab-
lishment of primary-cultured keratino-
cytes, immunofluorescence staining,
immunoblotting, and real-time reverse
transcriptase PCR analysis has been
previously described (Yanagi et al.,
2008, 2010). First, we investigated the
apoptosis of HI patient epidermis by
hematoxylin–eosin stain and TUNEL
assay (In situ Apoptosis Detection Kit,
Takara Bio, Otsu, Japan). In the HI
patients, the nuclei of the granular-layer
keratinocytes were condensed (Figure
1b) and they show positive for TUNEL
labeling (Figure 1d), although apoptotic
nuclei are rare in the normal human
epidermis (Figure 1a, c). The histo-
pathological findings and results of
TUNEL staining of the Abca12/ mice
were similar to those in the skin of the
HI patients (Figure 1f and h). TUNEL
staining in the epidermis of 18.5-day
embryos indicated that the apoptosis of
keratinocytes started during fetal skin
development (Figure 1j).
We assessed the degree of AKT
activation of Abca12/ skin and kera-
tinocytes using anti-AKT antibody
#4691 and anti-phosphorylated AKT
(Ser473) #4060 antibody (Cell Signal-
ing, Danvers, MA). By immunoblot
analysis, differentiated primary-cul-
tured keratinocytes and the epidermis
of Abca12/ mice showed higher
expression levels of Ser-473 phosphory-
lated AKT than those of the control
wild-type mice (Figure 1o). Immuno-
fluorescence staining detected phos-
phorylated AKT in the upper granular-
layer keratinocytes of the Abca12/
mouse skin (Figure 1l), but not in the
skin of control wild-type mouse (Figure
1k). Cell proliferation was assessed by
Ki-67 immunofluorescence (Figure 1).
Ki-67 stain was similar in the wild-type
and the Abca12/ samples, indicating
that the granular-layer keratinocytes
of the Abca12/ neonatal mice
showed no excessive cell proliferation.
To clarify whether AKT activation has
Abbreviations: ABCA12, ATP-binding cassette transporter A12; HI, harlequin ichthyosis; PPAR,
peroxisome proliferator-activated receptor; RXR, retinoid X receptor
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anti-apoptotic effects on Abca12/ ker-
atinocytes, we performed TUNEL stain-
ing of keratinocytes treated with AKT
inhibitor, which blocks AKT phosphor-
ylation (#124017; InSolution Akt Inhibi-
tor VIII, Calbiochem, San Diego, CA).
Abca12/ keratinocytes incubated with
10mM #124017 AKT inhibitor showed a
notably greater number of TUNEL-posi-
tive cells than both wild-type keratino-
cytes with AKT inhibitor and Abca12/
keratinocytes without AKT inhibitor (Fig-
ure 2). These results suggest that AKT
activation helps Abca12/ keratino-
cytes to avoid apoptosis. Furthermore,
mRNA and protein levels of peroxisome
proliferator-activated receptor (PPAR)-d
from Abca12/ epidermis were shown
to be significantly higher than those
from wild-type epidermis (Taqman
Gene Expression Assay, probe ID,
Mm00803184_m1, Mm99999915_g1,
Applied Biosystems, Carlsbad, CA;
anti-PPAR-d antibody H-74, Santa
Cruz, Santa Cruz, CA; Supplementary
Figure S1 online), which suggests upre-
gulation of PPAR-d as a candidate
pathway for AKT activation.
Herein, we have suggested that
apoptosis is involved in the pathome-
chanism of HI. Defective lipid transport
due to loss of ABCA12 function leads to
the accumulation of intracellular lipids,
including glucosylceramides and gang-
liosides (Akiyama et al., 2005; Mitsu-
take et al., 2010). Studies by Wang
et al. (2001) and Sun et al. (2002)
showed that the elevation of ganglio-
side levels leads to keratinocyte apop-
tosis. Thus, we are able to speculate
that the accumulation of gangliosides
leads to the apoptosis of Abca12/
keratinocytes, although the exact me-
chanism of apoptosis in Abca12/
keratinocytes remains unclear.
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Figure 1. ATP-binding cassette transporter A12-
deficient keratinocytes show TUNEL-positive
nuclei and AKT activation. (a–d) In the harlequin
ichthyosis patients, the nuclei of the granular-layer
keratinocytes are condensed (b, white arrows) and
they show positive TUNEL labeling (d, white
arrows), although apoptotic nuclei are rare in the
normal human epidermis (a, c). Data shown are
representative of those from the two harlequin
ichthyosis patients. (e, f) Granular-layer keratino-
cytes of Abca12/ mice show more condensed
nuclei (f, white arrows) than those of wild-type
mice (e). (g–j) Granular-layer keratinocytes of
Abca12/ mice, a neonate (h) and an 18.5-day
embryo (j), show TUNEL-positive nuclei. No
TUNEL-positive cells are seen in the epidermis of
the control wild-type mice (g, i). Dotted lines
indicate the basement membrane. Nonspecific
staining is seen on the skin surface (white arrow-
heads). (k, l) By immunofluorescence staining,
AKT activation (Ser-473 phosphorylated AKT;
green) is observed in granular-layer keratinocytes
of Abca12/ mice. (m, n) Immunofluorescence
staining for the Ki-67-proliferation marker shows
similar staining patterns of basal keratinocytes in
wild-type (m) and Abca12/ (n) samples. (a, b, e,
f; hematoxylin–eosin (H–E) stain. Bars of c, d, g, h,
i, j, k, l, m, n¼ 20 mm. Bars of a, b, e, f¼5 mm.) (o)
Immunoblot analysis shows that levels of serine-
473-phosphorylated AKT (pAKT) in neonatal
epidermis and differentiated keratinocytes of
Abca12/ mice are higher than those of
wild-type mice.
www.jidonline.org 1943
T Yanagi et al.
AKT in ABCA12-Deficient Keratinocytes
Although Abca12/ granular-layer
keratinocytes show characteristics of
apoptosis, including condensed nuclei
and positive TUNEL labeling, they are
able to form epidermal stratification.
In several disorders involving keratino-
cyte apoptosis, e.g., toxic epidermal
necrolysis, the apoptotic epidermal
keratinocytes show not only TUNEL-
positive nuclei but also defective epi-
dermal stratification (Abe et al., 2003).
Thrash et al. (2006) reported that AKT1
activation is an essential signal for
keratinocyte cell survival and stratifica-
tion, by experiments with gene silencing
and three-dimensional cell cultures.
Thus, we hypothesized that the AKT
pathway might work as a compensatory
mechanism against apoptosis in
Abca12/ keratinocytes. We have
clearly shown that AKT activation occurs
in Abca12/ granular-layer keratino-
cytes, which suggests that AKT activation
serves to prevent the cell death of
Abca12/ keratinocytes. By immuno-
blot analysis using anti-AKT1/2/3
antibodies (#2938/3063/3788, Cell
Signaling), Abca12/ epidermis showed
expression of AKT1 and AKT2, but not
AKT3 (Supplementary Figure S2 online).
Compared with wild-type epidermis,
Abca12/ epidermis seemed to have
more AKT1 than AKT2. From our data
and the literature (Thrash et al., 2006),
we are able to speculate that AKT1 is the
major isoform of phosphorylated AKT in
Abca12/ epidermis.
We have shown that PPAR-d is a
candidate molecule in the upstream
of the AKT activation pathway in
Abca12/ keratinocytes. Di-Poi et al.
(2002) reported that PPAR-d has an
anti-apoptotic role in keratinocytes
via transcriptional control of the
AKT1 signaling pathway. PPAR-d also
regulates the expression of ABCA12
(Jiang et al., 2008). From these studies,
we can speculate that upregulation
of PPAR-d is in response to apoptosis
or decreased ABCA12 expression. To
ascertain the function of PPAR-d,
we performed the experiments using a
PPAR-d-specific antagonist (GSK0660,
Santa Cruz). Differentiated Abca12/
keratinocytes treated with 1mM GSK0660
for 48 hours showed TUNEL-positive
nuclei, from which we are able to
speculate an anti-apoptotic role for
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Figure 2. Inhibition of AKT activation leads to apoptosis of Abca12/ keratinocytes. (a) Immunoblot
analysis indicates that the AKT inhibitor can inhibit AKT activation (phosphorylated AKT (pAKT)
synthesis) in differentiated keratinocytes. (b–e) TUNEL staining of keratinocytes cultured under high Ca2þ
condition treated with/without the AKT inhibitor. Neither wild-type cells (b) nor Abca12/ cells (c) are
TUNEL positive. Abca12/ keratinocytes with the AKT inhibitor (#124017; 10 mM) show many TUNEL-
positive nuclei (e), although only a small number of wild-type cells with the AKT inhibitor are TUNEL
positive (d). (Bars¼ 20 mm.) (f) Percentage of TUNEL-positive keratinocytes. Abca12/ keratinocytes
with AKT inhibitor shows a significantly greater number of TUNEL-positive nuclei than wild-type
keratinocytes with/without the AKT inhibitor and Abca12/ keratinocytes without the AKT inhibitor.
(n¼3, mean±SD, *Po0.05).
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PPAR-d in Abca12/ keratinocytes
(Supplementary Figure S1 online). From
our studies and the literature (Di-Poi
et al., 2002), PPAR-d has been shown to
have at least an anti-apoptotic role in
Abca12/ keratinocytes; however, it
remains unclear whether the upregula-
tion of PPAR-d is in response to apoptosis
or decreased ABCA12 expression.
Furthermore, we have measured the
mRNA expression levels of other nucle-
ar hormone receptors, including PPAR-
a, PPAR-g, retinoic acid receptor-a,
liver X receptor-a, liver X receptor-b,
RXR-a, and RXR-g (Applied Biosys-
tems). The mRNA level of RXR-a from
Abca12/ epidermis was shown to be
significantly higher than that from wild-
type epidermis (Supplementary Figure
S1 online). The interaction between the
upregulation of RXR-a and AKT activa-
tion in keratinocytes has not been
reported. However, Wang et al. (2011)
reported that RXR-a ablation in the
epidermis enhances UV-induced apop-
tosis, which suggests that RXR-a has an
anti-apoptotic function in keratino-
cytes. Thus, upregulation of RXR-a
may also have an anti-apoptotic func-
tion in Abca12/ keratinocytes.
In conclusion, the present data
suggest that keratinocyte apoptosis is
involved in the pathomechanisms of HI
and that the AKT signaling pathway
helps Abca12/ keratinocytes to sur-
vive during the keratinization process.
In light of this, activation of the AKT
signal pathway may be to our knowl-
edge, previously unreported strategy
for treating keratinization disorders,
including ichthyosis.
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TO THE EDITOR
Health-related quality of life (HRQL) is
commonly assessed by means of standar-
dized questionnaires and expressed in
domain and overall HRQL scores. An
important challenge is to interpret these
scores correctly. What does a given score
really mean? Although there is no standard
approach, several methods exist to facil-
itate the interpretation of HRQL scores.
In a recently published study
(Prinsen et al., 2010), we identified
See related commentary on pg 1790
Abbreviation: HRQL, health-related quality of life
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